Video

The Challenges of a Mid-Sized Specialty Pharmacy

Michael Nameth, RPh, MBA, chief executive officer of Aureus Health Services, discusses the major hurdles facing mid-size specialty pharmacies.

Michael Nameth, RPh, MBA, chief executive officer of Aureus Health Services, discusses the major hurdles facing mid-size specialty pharmacies.

This video was shot at the Armada Health Care 2014 Specialty Pharmacy Summit and Expo in Las Vegas, Nevada.

Related Videos
Happy elderly patient with medical health checkup with cardiologist or geriatric doctor. Senior old aging woman with coronary artery heart disease or cardiac illness check-up in clinic - Image credit: Chinnapong | stock.adobe.com
Pharmacist and patient in a retail/community pharmacy setting -- Image credit: Zamrznuti tonovi | stock.adobe.com
Menoapuse spelled with wooden blocks -- Image credit: loran4a | stock.adobe.com
Related Content
Newborn baby -- Image credit: kieferpix | stock.adobe.com
May 8th 2025

INF108 Granted Orphan Drug Designation, Rare Pediatric Drug Designation for Preterm Infants With NEC

Gillian McGovern, Associate Editor
Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder
March 31st 2025

Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder

Luke Halpern, Assistant Editor
Liver with fibrosis -- Image credit: Rasi | stock.adobe.com
May 6th 2025

Study Demonstrates Semaglutide Improves Liver Histologic Results in Patients With MASH

Gillian McGovern, Associate Editor
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
February 28th 2025

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

Luke Halpern, Assistant Editor Jill Simonian, PharmD Codi Peterson, PharmD, MS
Pharmacy students in a fellowship -- Image credit: Seventyfour | stock.adobe.com
May 5th 2025

Transformative Pharmacy Fellowships Can Shape Future Leaders

Mike Hennessy Jr, President and CEO
Trial Data Show Long-Term Safety, Efficacy of Xanomeline/Trospium for Schizophrenia
May 4th 2025

Trial Data Show Long-Term Safety, Efficacy of Xanomeline/Trospium for Schizophrenia

Aislinn Antrim, Managing Editor